The S218L familial hemiplegic migraine mutation promotes deinhibition of Ca(v)2.1 calcium channels during direct G-protein regulation

Pflugers Arch. 2008 Nov;457(2):315-26. doi: 10.1007/s00424-008-0541-2. Epub 2008 Jun 26.

Abstract

Familial hemiplegic migraine type 1 (FHM-1) is caused by mutations in CACNA1A, the gene encoding for the Ca(v)2.1 subunit of voltage-gated calcium channels. Although various studies attempted to determine biophysical consequences of these mutations on channel activity, it remains unclear exactly how mutations can produce a FHM-1 phenotype. A lower activation threshold of mutated channels resulting in increased channel activity has been proposed. However, hyperactivity may also be caused by a reduction of the inhibitory pathway carried by G-protein-coupled-receptor activation. The aim of this study is to determine functional consequences of the FHM-1 S218L mutation on direct G-protein regulation of Ca(v)2.1 channels. In HEK 293 cells, DAMGO activation of human mu-opioid receptors induced a 55% Ba(2+) current inhibition through both wild-type and S218L mutant Ca(v)2.1 channels. In contrast, this mutation considerably accelerates the kinetic of current deinhibition following channel activation by 1.7- to 2.3-fold depending on membrane potential values. Taken together, these data suggest that the S218L mutation does not affect G-protein association onto the channel in the closed state but promotes its dissociation from the activated channel, thereby decreasing the inhibitory G-protein pathway. Similar results were obtained with the R192Q FHM-1 mutation, although of lesser amplitude, which seems in line with the less severe associated clinical phenotype in patients. Functional consequences of FHM-1 mutations appear thus as the consequence of the alteration of both intrinsic biophysical properties and of the main inhibitory G-protein pathway of Ca(v)2.1 channels. The present study furthers molecular insight in the physiopathology of FHM-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channels / genetics
  • Calcium Channels / metabolism*
  • Calcium Channels, L-Type
  • Calcium Channels, N-Type / genetics
  • Calcium Channels, N-Type / metabolism*
  • Cell Line
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism*
  • Genotype
  • Humans
  • Ion Channel Gating* / drug effects
  • Kinetics
  • Membrane Potentials
  • Migraine with Aura / genetics
  • Migraine with Aura / metabolism*
  • Mutation*
  • Phenotype
  • Rats
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / metabolism
  • Transfection

Substances

  • CACNA1A protein, human
  • Cacna2d1 protein, rat
  • Cacnb4 protein, rat
  • Calcium Channels
  • Calcium Channels, L-Type
  • Calcium Channels, N-Type
  • Receptors, Opioid, mu
  • voltage-dependent calcium channel (P-Q type)
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • GTP-Binding Protein alpha Subunits, Gi-Go